Thank you for sharing!

Your article was successfully shared with the contacts you provided.

As The Am Law Litigation Daily reported last week, AstraZeneca received some bad news on Wednesday from the 1st Circuit, which affirmed a lower court’s ruling in a test case in the multi-district proceeding over drug companies’ alleged manipulation of average wholesale prices for drugs. Although the 1st Circuit ruling spells trouble for the company in the MDL, plaintiffs attorney Steven Berman of Hagens Berman told us that it may not have an impact on the cases brought against AstraZeneca by various state and local governments, which are using slightly different theories to show that Big Pharma manipulated the published prices of their drugs.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.